Clinical Trials Logo

Filter by:
NCT ID: NCT02128269 Completed - Clinical trials for Antiphospholipid (aPL)-Positive

Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Start date: April 2014
Phase: Phase 2
Study type: Interventional

The primary purpose of this study is to evaluate the safety and tolerability of intravenous (IV) ALXN1007 in persistently antiphospholipid (aPL)-positive patients with at least 1 of the following non-criteria manifestations of APS: aPL-nephropathy, skin ulcers and/or thrombocytopenia.

NCT ID: NCT02127723 Completed - Clinical trials for Cellulite of the Buttocks

(Macrolane VR30) in Buttocks Reshaping and contouringCellulite (Macrolane VR30) in Buttocks Reshaping and Contouring

Start date: April 2014
Phase: N/A
Study type: Interventional

The most common treatments today for enhancing the shape and size of the buttocks are transplantation of the patient's own body fat after liposuction and insertion of permanent implants. Macrolane VRF30 is a gel product based on hyaluronic acid which is a transparent slow-flowing gel. A similar hyaluronic-acid gel from the same manufacturer, Q-Med AB, has been used for many years for the treatment of facial wrinkles. By injecting Macrolane gel into the skin, the shape of the buttocks can be altered and their volume increased.

NCT ID: NCT02127411 Completed - Clinical trials for Benzodiazepine Dependence

Effectiveness of Mindfulness Based Relapse Prevention for Chronic Users of Benzodiazepines

MBRP
Start date: October 2013
Phase: N/A
Study type: Interventional

Benzodiazepines (BZD) are the most prescribed psychiatric drugs in Brazil, especially for women. Although it is recommended that the use of BZD is not greater than four weeks, there are many cases of prolonged use due to the lack of treatment options for dealing with complaints of insomnia. Given this, the aim of this project is to evaluate the program Mindfulness-Based Relapse Prevention (MBRP) for adult women with chronic use of benzodiazepine (BZD) to induce sleep. Specifically aims to evaluate if the MBRP program, can reduce the pattern of use and level of dependence of chronic users of BZD under gradual reduction (tapering) or cessation of the use of BZD. This study will be conducted at the Drug Dependency Unit (UDED) of the Department of Psychobiology of Federal University of São Paulo. The study will count with two groups: intervention group (IG) and control group (CG) (that will stay in the waitlist until the eighth month . The sample will comprise 100 women with chronic use of BZD as hypnotics, 50 will be randomized in the IG condition and 50 in the CG condition. Changes will be evaluated on several variables such as cessation and dependence of BZD, quality of life, sleep, anxiety, depression and sexual satisfaction before and after the intervention in both groups. The data will be submitted to descriptive and inferential bivariate and multivariate statistic analyzes. It is hoped that this study create subsidies for the development of complementary interventions for the management of withdrawal symptoms in chronic users of BZD.

NCT ID: NCT02126267 Completed - Clinical trials for Chronic Periodontitis

Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection

Start date: January 2013
Phase: N/A
Study type: Interventional

Evaluate and compare the effectiveness in a clinical and microbial perspective one stage full-mouth disinfection technique in relation to scaling and root planing per quadrant associated with chlorhexidine or azithromycin.

NCT ID: NCT02124525 Recruiting - Inflammation Clinical Trials

N-acetylcysteine for Tobacco Smoking

NACNOS
Start date: February 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy of N-acetylcysteine (NAC) for smoking cessation in a double blind, randomized, placebo-controlled trial. Simultaneously, the study aims to elucidate the role of inflammatory markers and oxidative stress related to nicotine addiction and the use of NAC, an acetylated precursor of cysteine, a naturally occurring amino acid that has antioxidant actions in its own right, in reducing oxidative stress and inflammation in smokers. It will evaluate the use of NAC in smoking cessation, after 4, 8 and 12 weeks of treatment.

NCT ID: NCT02124005 Completed - Postoperative Pain Clinical Trials

Evaluation of the Minimum Effective Concentration of Bupivacaine (EC50) in Femoral Block for Analgesia by Ultrasound After Knee Surgery

Start date: July 2013
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the minimum effective concentration of bupivacaine (EC50) in femoral block for analgesia by ultrasound after knee surgery.

NCT ID: NCT02123667 Completed - Asthma Clinical Trials

AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)

ATLANTIS
Start date: June 30, 2014
Phase:
Study type: Observational

Multinational, multicentre, non-pharmacological intervention, cross-sectional and longitudinal study.

NCT ID: NCT02123563 Completed - Obesity Clinical Trials

Mechanical-chemical Gingival Therapy in Diabetics and/or Obese

MCGTDO
Start date: June 2012
Phase: Phase 4
Study type: Interventional

Diabetes and obesity affect many people in different countries. Similarly, millions of people have some type of gum disease such as gingivitis. The present study was conducted to clarify if systemic conditions such as diabetes and obesity could impair the response to gingivitis treatment. Subjects with gum disease showing diabetes type II (from 40 to 50 subjects), slight to moderate obesity (from 40 to 50 subjects) or its combination (from 40 to 50 subjects) were selected for the present study. In addition normal-weight subjects with gum disease (from 40 to 50 subjects) besides a group without gum disease (from 40 to 50 subjects) were selected for comparisons. After verbal and written explanations about the study, subjects who matched study criteria and who signed the informed consent form underwent full oral examinations in two separate visits. In the first visit, after a clinical examination to verify the levels of gingival inflammation and the accumulated amounts of dental plaque, the bone height was determined by X-Ray examinations. Bad breath was also evaluated by a chair-side apparatus. Additional laboratorial examinations included a) quantification of bacteria that cause gum disease from dental plaque samples, b) quantification of inflammatory products from gingival fluid sampling and c) quantification of produced saliva. Self-report questionnaires were used to check the impact of oral condition and treatment of gum disease in quality of life and individual daily performance. These examinations were repeated 3 months after dental treatment. All subjects received ultrasonic dental prophylaxis for cleaning their teeth. Based on systemic/oral conditions each group rinsed either an essential-oils containing mouth rinse or a placebo rinse. First rinse was supervised and the other ones were performed at home twice a day for three months. Each participant also received a toothbrush, a dental floss and a fluoride toothpaste monthly after oral hygiene instructions. Adherence to the treatment and occurrence of undesirable side effects were monitored throughout the study.

NCT ID: NCT02123394 Completed - Clinical trials for Non-specific Chronic Low Back Pain

Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain

Mckenzie
Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of the McKenzie method in patients with chronic non-specific low back.

NCT ID: NCT02122848 Completed - Heart Failure Clinical Trials

Exercise Tolerance in Patients With Decompensated Heart Failure

Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of airway bilevel positive pressure on the improvement of exercise tolerance in patients with decompensated heart failure.